Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials
Titel:
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials
Auteur:
Fizazi, K. Flaig, T.W. Stöckle, M. Scher, H.I. de Bono, J.S. Rathkopf, D.E. Ryan, C.J. Kheoh, T. Li, J. Todd, M.B. Griffin, T.W. Molina, A. Ohlmann, C.H.